27 top medical experts on Late-Onset Carnitine Palmitoyltransferase II Deficiency across 4 countries and 1 U.S. states, including 2 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Late-Onset Carnitine Palmitoyltransferase II Deficiency: The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency (see this term).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Synonyms: Myopathic CPT II Deficiency,  Late-Onset CPT2 Deficiency,  Adult-Onset Carnitine Palmitoyltransferase II Deficiency,  Myopathic Carnitine Palmitoyltransferase II Deficiency


  

        

                    


    Computing Expert Listing ...